2021 ANSTO/ANZSNM Research Grant Winner
Ashleigh Hull, University of South Australia
Preclinical Studies of MUC1 Targeted Alpha Therapy for Pancreatic Cancer
We would like to thank ANSTO and ANZSNM for their generous support of our research.
Ashleigh Hull 1,2*, Yanrui Li 1, Dylan Bartholomeusz 2,3, William Hsieh 1,2 and Eva Bezak 1,4
1 Cancer Research Institute and Allied Health and Human Performance Academic Unit, University of South Australia, Adelaide SA 5001, Australia;
2 Department of PET, Nuclear Medicine & Bone Densitometry, Royal Adelaide Hospital, SA Medical Imaging, Adelaide SA 5000, Australia.
3 Adelaide Medical School, The University of Adelaide, Adelaide SA 5000, Australia.
4 School of Physical Sciences, The University of Adelaide, Adelaide SA 5000, Australia.
%20(2).png)
.jpg){kind=logo}
